Johanna Meyer, Heidelberg Engineering (F);
Janine Gross, None;
Frank Holz, Acucela (C), Acucela (F), Acucela (R), Allergan (F), Allergan (R), Appelis (C), Bayer (F), Bayer (C), Bioeq/Formycon (F), Bioeq/Formycon (C), Boehringer-Ingelheim (C), Carl Zeiss MedicTec (F), CenterVue (F), Ellex (R), Geuder (C), Grayburg Vision (C), Heidelberg Engineering (C), LinBioscience (C), NightStarX (F), Novartis (C), Optos (F), Oxurion (C), Pixium Vision (C), Roche/Genentech (C), Stealth BioTherapeutics (C);
Steffen Schmitz-Valckenberg, Acucela (F), Alcon/Novartis (F), Alcon/Novartis (C), Alcon/Novartis (R), Allergan (F), Allergan (C), Allergan (R), Bayer (F), Bayer (R), Bioeq/Formycon (F), Bioeq/Formycon (C), Carl Zeiss MedicTec (F), Carl Zeiss MedicTec (R), CenterVue (F), Galimedix (C), Genentech/Roche (F), Genentech/Roche (R), Heidelberg Engineering (F), Katairo (F), Optos (F)